Èlia Ripoll

532 total citations
17 papers, 424 citations indexed

About

Èlia Ripoll is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Èlia Ripoll has authored 17 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Immunology and 6 papers in Surgery. Recurrent topics in Èlia Ripoll's work include RNA Interference and Gene Delivery (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Èlia Ripoll is often cited by papers focused on RNA Interference and Gene Delivery (5 papers), Systemic Lupus Erythematosus Research (4 papers) and Renal Transplantation Outcomes and Treatments (3 papers). Èlia Ripoll collaborates with scholars based in Spain, Sweden and Netherlands. Èlia Ripoll's co-authors include Joan Torrás, Josep M. Grinyó, Josep M. Cruzado, Marcella Franquesa, Montse Gomà, Núria Lloberas, I. Herrero, Ana Merino, Maria Flaquer and Josep M. Aran and has published in prestigious journals such as PLoS ONE, Kidney International and Frontiers in Immunology.

In The Last Decade

Èlia Ripoll

17 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Èlia Ripoll Spain	11	160	123	122	120	66	17	424
Weijun Tian China	13	140 0.9×	77 0.6×	122 1.0×	49 0.4×	19 0.3×	24	420
Sandra Villanueva Chile	9	263 1.6×	38 0.3×	156 1.3×	201 1.7×	13 0.2×	11	501
Dan Draganovici Germany	8	71 0.4×	199 1.6×	52 0.4×	38 0.3×	50 0.8×	8	417
Ying‐Hua Cheng United States	14	296 1.9×	125 1.0×	36 0.3×	116 1.0×	28 0.4×	32	635
Jean-Paul Duong-Van-Huyen France	5	153 1.0×	87 0.7×	189 1.5×	59 0.5×	14 0.2×	8	475
Mehtat Ünlü Türkiye	11	70 0.4×	88 0.7×	93 0.8×	73 0.6×	23 0.3×	36	339
Thierry P. P. van den Bosch Netherlands	11	143 0.9×	88 0.7×	59 0.5×	14 0.1×	19 0.3×	37	356
Xiao-Shun He China	10	79 0.5×	112 0.9×	112 0.9×	98 0.8×	27 0.4×	21	453
Wenchao Li China	12	152 0.9×	138 1.1×	61 0.5×	164 1.4×	73 1.1×	14	382
Émilie Groyer France	9	67 0.4×	184 1.5×	54 0.4×	22 0.2×	25 0.4×	12	329

Countries citing papers authored by Èlia Ripoll

Since Specialization

Citations

This map shows the geographic impact of Èlia Ripoll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Èlia Ripoll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Èlia Ripoll more than expected).

Fields of papers citing papers by Èlia Ripoll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Èlia Ripoll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Èlia Ripoll. The network helps show where Èlia Ripoll may publish in the future.

Co-authorship network of co-authors of Èlia Ripoll

This figure shows the co-authorship network connecting the top 25 collaborators of Èlia Ripoll. A scholar is included among the top collaborators of Èlia Ripoll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Èlia Ripoll. Èlia Ripoll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Hueso, Miguel, Èlia Ripoll, Cristián Varela, et al.. (2021). In vivo CD40 Silencing by siRNA Infusion in Rodents and Evaluation by Kidney Immunostaining. BIO-PROTOCOL. 11(10). e4032–e4032. 2 indexed citations

Ripoll, Èlia, Pere Fontova, Núria Lloberas, et al.. (2021). The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis. Molecular Therapy — Nucleic Acids. 24. 807–821. 11 indexed citations

Luque, Ana, Èlia Ripoll, Montserrat Gomà‐i‐Freixanet, et al.. (2019). Noncanonical immunomodulatory activity of complement regulator C4BP(β-) limits the development of lupus nephritis. Kidney International. 97(3). 551–566. 12 indexed citations

Merino, Ana, Èlia Ripoll, Montserrat Gomà‐i‐Freixanet, et al.. (2017). The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation. Cell Transplantation. 26(6). 1017–1030. 16 indexed citations

Ripoll, Èlia, Juliana Draibe, Ana Merino, et al.. (2016). JAK3-STAT pathway blocking benefits in experimental lupus nephritis. Arthritis Research & Therapy. 18(1). 134–134. 42 indexed citations

Jarque, Marta, et al.. (2016). RNAi-Based Therapy in Experimental Ischemia-Reperfusion Injury. The New Targets. Current Pharmaceutical Design. 22(30). 4651–4657. 5 indexed citations

Hueso, Miguel, Estanis Navarro, Èlia Ripoll, et al.. (2016). Silencing of CD40 in vivo reduces progression of experimental atherogenesis through an NF-κB/miR-125b axis and reveals new potential mediators in the pathogenesis of atherosclerosis. Atherosclerosis. 255. 80–89. 34 indexed citations

Hueso, Miguel, Estanis Navarro, Èlia Ripoll, et al.. (2016). Datasets for the validation of the "in vivo" siRNA-silencing of CD40 and for the detection of new markers of atherosclerosis progression in ApoE-deficient mice. Data in Brief. 9. 1105–1112. 5 indexed citations

Draibe, Juliana, Rafael Poveda, Xavier Fulladosa, et al.. (2015). Use of mycophenolate in ANCA-associated renal vasculitis: 13 years of experience at a university hospital. Nephrology Dialysis Transplantation. 30(suppl_1). i132–i137. 14 indexed citations

10.

Ripoll, Èlia, Ana Merino, Marc Lúcia, et al.. (2015). CD154-CD40 T-cell co-stimulation pathway is a key mechanism in kidney ischemia-reperfusion injury. Kidney International. 88(3). 538–549. 25 indexed citations

11.

Franquesa, Marcella, Martin J. Hoogduijn, Èlia Ripoll, et al.. (2014). Update on Controls for Isolation and Quantification Methodology of Extracellular Vesicles Derived from Adipose Tissue Mesenchymal Stem Cells. Frontiers in Immunology. 5. 525–525. 74 indexed citations

12.

Ripoll, Èlia, Ana Merino, Montse Gomà, et al.. (2013). CD40 Gene Silencing Reduces the Progression of Experimental Lupus Nephritis Modulating Local Milieu and Systemic Mechanisms. PLoS ONE. 8(6). e65068–e65068. 28 indexed citations

13.

Ripoll, Èlia, Ana Merino, Josep M. Grinyó, & Joan Torrás. (2013). New Approaches for the Treatment of Lupus Nephritis in the 21st Century: From the Laboratory to the Clinic. Immunotherapy. 5(10). 1089–1101. 5 indexed citations

14.

Franquesa, Marcella, Joan Torrás, Èlia Ripoll, et al.. (2012). Mesenchymal Stem Cell Therapy Prevents Interstitial Fibrosis and Tubular Atrophy in a Rat Kidney Allograft Model. Stem Cells and Development. 21(17). 3125–3135. 108 indexed citations

15.

Ripoll, Èlia, Víctor Nacher, August Vidal, et al.. (2012). Cold ischaemia, innate immunity and deterioration of the glomerular filtration barrier in antibody-mediated acute rejection. Nephrology Dialysis Transplantation. 27(8). 3296–3305. 5 indexed citations

16.

Ripoll, Èlia, Raquel Pluvinet, Joan Torrás, et al.. (2011). In vivo therapeutic efficacy of intra-renal CD40 silencing in a model of humoral acute rejection. Gene Therapy. 18(10). 945–952. 29 indexed citations

17.

Móra, Josefina, et al.. (2009). Genetic Mutations in a Spanish Population with Chronic Pancreatitis. Pancreatology. 9(5). 644–651. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact